CDK9-IN-26
Product Specifications
UNSPSC Description
CDK9-IN-26 (compound 1is a CDK9 inhibitor (IC50=0.18 μM). [1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-26.html
Solubility
10 mM in DMSO
Smiles
COC1=CC=C(NC2=C(C3=COC=C3)N=C4C=NC=CN42)C=C1
Molecular Weight
306.32
References & Citations
[1]Alsfouk AA, et al. New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches. Pharmaceuticals (Basel). 2023 Jul 18;16(7):1018.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-155844/CDK9-IN-26-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-155844/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6197171-01 0.1 mL
PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1, BMIQ12, NEC1, PC1, PC3, SPC3) (MaxLight 405)
Ask
View Details MBS6197171-02 5x 0.1 mL
PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1, BMIQ12, NEC1, PC1, PC3, SPC3) (MaxLight 405)
Ask
View Details